{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:06:43Z","timestamp":1787314003283,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Three-year planning of the Shanghai Shen-Kang Promoting Hospital\u2019s Clinical Skills and Innovative Ability Project","award":["16CR3110B"],"award-info":[{"award-number":["16CR3110B"]}]},{"name":"Shanghai Municipal Key Clinical Specialty","award":["shslczdzk03403"],"award-info":[{"award-number":["shslczdzk03403"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00277-021-04466-3","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T21:02:49Z","timestamp":1614286969000},"page":"1039-1047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Dynamic evaluation of the prognostic value of 18F-FDG PET\/CT in extranodal NK\/T-cell lymphoma, nasal type"],"prefix":"10.1007","volume":"100","author":[{"given":"Pengpeng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengye","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0493-2062","authenticated-orcid":false,"given":"Biao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"issue":"2","key":"4466_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/annonc\/mdi037","volume":"16","author":"WY Au","year":"2005","unstructured":"Au WY, Ma SY, Chim CS, Choy C, Loong F, Lie AK, Lam CC, Leung AY, Tse E, Yau CC, Liang R, Kwong YL (2005) Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. Ann Oncol 16(2):206\u2013214. https:\/\/doi.org\/10.1093\/annonc\/mdi037","journal-title":"Ann Oncol"},{"issue":"9","key":"4466_CR2","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1046\/j.1440-1827.2000.01108.x","volume":"50","author":"The world health organization classification of malignant lymphomas in japan","year":"2000","unstructured":"The world health organization classification of malignant lymphomas in japan (2000) incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int 50(9):696\u2013702","journal-title":"Pathol Int"},{"issue":"7","key":"4466_CR3","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/annonc\/mdh263","volume":"15","author":"CY Chen","year":"2004","unstructured":"Chen CY, Yao M, Tang JL, Tsay W, Wang CC, Chou WC, Su IJ, Lee FY, Liu MC, Tien HF (2004) Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin\u2019s lymphoma in Taiwan: with special reference to T-cell lymphoma. Ann Oncol 15(7):1091\u20131096. https:\/\/doi.org\/10.1093\/annonc\/mdh263","journal-title":"Ann Oncol"},{"issue":"3","key":"4466_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.beha.2019.06.005","volume":"32","author":"E Tse","year":"2019","unstructured":"Tse E, Kwong YL (2019) NK\/T-cell lymphomas. Best Pract Res Clin Haematol 32(3):253\u2013261. https:\/\/doi.org\/10.1016\/j.beha.2019.06.005","journal-title":"Best Pract Res Clin Haematol"},{"issue":"23","key":"4466_CR5","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1182\/blood-2017-12-791418","volume":"131","author":"M Yamaguchi","year":"2018","unstructured":"Yamaguchi M, Suzuki R, Oguchi M (2018) Advances in the treatment of extranodal NK\/T-cell lymphoma, nasal type. Blood 131(23):2528\u20132540. https:\/\/doi.org\/10.1182\/blood-2017-12-791418","journal-title":"Blood"},{"issue":"2","key":"4466_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12185-015-1809-x","volume":"102","author":"H Ding","year":"2015","unstructured":"Ding H, Chang J, Liu LG, Hu D, Zhang WH, Yan Y, Ma LY, Li ZC, Ma YJ, Hao SG, Tao R (2015) High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed\/refractory extranodal natural killer\/T cell lymphoma: a retrospective study. Int J Hematol 102(2):181\u2013187. https:\/\/doi.org\/10.1007\/s12185-015-1809-x","journal-title":"Int J Hematol"},{"issue":"4","key":"4466_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/hon.2325","volume":"35","author":"R Liang","year":"2017","unstructured":"Liang R, Gao GX, Chen JP, Wang JS, Wang XM, Zeng Y, Bai QX, Zhang T, Yang L, Dong BX, Gu HT, Shu MM, Hao CX, Wang JH, Zhang N, Chen XQ (2017) A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer\/T-cell lymphoma, nasal type: a multicenter trial in Northwest China. Hematol Oncol 35(4):619\u2013629. https:\/\/doi.org\/10.1002\/hon.2325","journal-title":"Hematol Oncol"},{"key":"4466_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ebiom.2017.10.011","volume":"25","author":"PP Xu","year":"2017","unstructured":"Xu PP, Xiong J, Cheng S, Zhao X, Wang CF, Cai G, Zhong HJ, Huang HY, Chen JY, Zhao WL (2017) A phase ii study of methotrexate, etoposide, dexamethasone and pegaspargase sandwiched with radiotherapy in the treatment of newly diagnosed, stage IE to IIE extranodal natural-killer\/T-cell lymphoma, nasal-type. EBioMedicine 25:41\u201349. https:\/\/doi.org\/10.1016\/j.ebiom.2017.10.011","journal-title":"EBioMedicine"},{"issue":"3","key":"4466_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","volume":"17","author":"SJ Kim","year":"2016","unstructured":"Kim SJ, Yoon DH, Jaccard A, Chng WJ, Lim ST, Hong H, Park Y, Chang KM, Maeda Y, Ishida F, Shin DY, Kim JS, Jeong SH, Yang DH, Jo JC, Lee GW, Choi CW, Lee WS, Chen TY, Kim K, Jung SH, Murayama T, Oki Y, Advani R, d'Amore F, Schmitz N, Suh C, Suzuki R, Kwong YL, Lin TY, Kim WS (2016) A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol 17(3):389\u2013400. https:\/\/doi.org\/10.1016\/S1470-2045(15)00533-1","journal-title":"Lancet Oncol"},{"issue":"14","key":"4466_CR10","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1200\/JCO.2010.32.5225","volume":"29","author":"BD Cheson","year":"2011","unstructured":"Cheson BD (2011) Role of functional imaging in the management of lymphoma. J Clin Oncol 29(14):1844\u20131854. https:\/\/doi.org\/10.1200\/JCO.2010.32.5225","journal-title":"J Clin Oncol"},{"issue":"7","key":"4466_CR11","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2967\/jnumed.112.113399","volume":"54","author":"SH Moon","year":"2013","unstructured":"Moon SH, Cho SK, Kim WS, Kim SJ, Chan Ahn Y, Choe YS, Lee KH, Kim BT, Choi JY (2013) The role of 18F-FDG PET\/CT for initial staging of nasal type natural killer\/T-cell lymphoma: a comparison with conventional staging methods. J Nucl Med 54(7):1039\u20131044. https:\/\/doi.org\/10.2967\/jnumed.112.113399","journal-title":"J Nucl Med"},{"issue":"2","key":"4466_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.rcl.2008.03.004","volume":"46","author":"M Allen-Auerbach","year":"2008","unstructured":"Allen-Auerbach M, de Vos S, Czernin J (2008) The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients. Radiol Clin N Am 46(2):199\u2013211, vii. https:\/\/doi.org\/10.1016\/j.rcl.2008.03.004","journal-title":"Radiol Clin N Am"},{"issue":"1","key":"4466_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2967\/jnumed.107.039867","volume":"49","author":"T Terasawa","year":"2008","unstructured":"Terasawa T, Nihashi T, Hotta T, Nagai H (2008) 18F-FDG PET for posttherapy assessment of Hodgkin\u2019s disease and aggressive Non-Hodgkin's lymphoma: a systematic review. J Nucl Med 49(1):13\u201321. https:\/\/doi.org\/10.2967\/jnumed.107.039867","journal-title":"J Nucl Med"},{"issue":"3","key":"4466_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MNM.0b013e32833310fa","volume":"31","author":"HB Wu","year":"2010","unstructured":"Wu HB, Wang QS, Wang MF, Li HS, Zhou WL, Ye XH, Wang QY (2010) Utility of 18F-FDG PET\/CT for staging NK\/T-cell lymphomas. Nucl Med Commun 31(3):195\u2013200. https:\/\/doi.org\/10.1097\/MNM.0b013e32833310fa","journal-title":"Nucl Med Commun"},{"issue":"28","key":"4466_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000258","volume":"93","author":"X Zhou","year":"2014","unstructured":"Zhou X, Lu K, Geng L, Li X, Jiang Y, Wang X (2014) Utility of PET\/CT in the diagnosis and staging of extranodal natural killer\/T-cell lymphoma: a systematic review and meta-analysis. Medicine (Baltimore) 93(28):e258. https:\/\/doi.org\/10.1097\/MD.0000000000000258","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"4466_CR16","first-page":"83","volume":"102","author":"E Sabattini","year":"2010","unstructured":"Sabattini E, Bacci F, Sagramoso C, Pileri SA (2010) WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica 102(3):83\u201387","journal-title":"Pathologica"},{"issue":"11","key":"4466_CR17","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on Hodgkin\u2019s disease staging classification. Cancer Res 31(11):1860\u20131861","journal-title":"Cancer Res"},{"issue":"8","key":"4466_CR18","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/10428190903040048","volume":"50","author":"M Meignan","year":"2009","unstructured":"Meignan M, Gallamini A, Meignan M, Gallamini A, Haioun C (2009) Report on the first international workshop on interim-pet-scan in lymphoma. Leukemia Lymphoma 50(8):1257\u20131260. https:\/\/doi.org\/10.1080\/10428190903040048","journal-title":"Leukemia Lymphoma"},{"issue":"1","key":"4466_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3978\/j.issn.2304-3865.2014.11.03","volume":"4","author":"BD Cheson","year":"2015","unstructured":"Cheson BD (2015) Staging and response assessment in lymphomas: the new Lugano classification. Chin Clin Oncol 4(1):5. https:\/\/doi.org\/10.3978\/j.issn.2304-3865.2014.11.03","journal-title":"Chin Clin Oncol"},{"issue":"21","key":"4466_CR20","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","volume":"23","author":"H Schoder","year":"2005","unstructured":"Schoder H, Noy A, Gonen M, Weng L, Green D, Erdi YE, Larson SM, Yeung HW (2005) Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin\u2019s lymphoma. J Clin Oncol 23(21):4643\u20134651. https:\/\/doi.org\/10.1200\/JCO.2005.12.072","journal-title":"J Clin Oncol"},{"issue":"6","key":"4466_CR21","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2967\/jnumed.113.131946","volume":"55","author":"PL Khong","year":"2014","unstructured":"Khong PL, Huang B, Lee EY, Chan WK, Kwong YL (2014) Midtreatment (1)(8)F-FDG PET\/CT scan for early response assessment of SMILE therapy in natural killer\/T-cell lymphoma: a prospective study from a single center. J Nucl Med 55(6):911\u2013916. https:\/\/doi.org\/10.2967\/jnumed.113.131946","journal-title":"J Nucl Med"},{"issue":"10","key":"4466_CR22","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/RLU.0000000000000892","volume":"40","author":"C Jiang","year":"2015","unstructured":"Jiang C, Su M, Kosik RO, Zou L, Jiang M, Tian R (2015) The Deauville 5-point scale improves the prognostic value of interim FDG PET\/CT in extranodal natural killer\/T-cell lymphoma. Clin Nucl Med 40(10):767\u2013773. https:\/\/doi.org\/10.1097\/RLU.0000000000000892","journal-title":"Clin Nucl Med"},{"issue":"8","key":"4466_CR23","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1182\/blood-2008-05-160176","volume":"112","author":"YX Li","year":"2008","unstructured":"Li YX, Fang H, Liu QF, Lu J, Qi SN, Wang H, Jin J, Wang WH, Liu YP, Song YW, Wang SL, Liu XF, Feng XL, Yu ZH (2008) Clinical features and treatment outcome of nasal-type NK\/T-cell lymphoma of Waldeyer ring. Blood 112(8):3057\u20133064. https:\/\/doi.org\/10.1182\/blood-2008-05-160176","journal-title":"Blood"},{"issue":"11","key":"4466_CR24","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2967\/jnumed.108.053355","volume":"49","author":"C Suh","year":"2008","unstructured":"Suh C, Kang YK, Roh JL, Kim MR, Kim JS, Huh J, Lee JH, Jang YJ, Lee BJ (2008) Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer\/T-cell lymphomas of the head and neck. J Nucl Med 49(11):1783\u20131789. https:\/\/doi.org\/10.2967\/jnumed.108.053355","journal-title":"J Nucl Med"},{"issue":"5","key":"4466_CR25","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s12149-015-0964-8","volume":"29","author":"C Jiang","year":"2015","unstructured":"Jiang C, Zhang X, Jiang M, Zou L, Su M, Kosik RO, Tian R (2015) Assessment of the prognostic capacity of pretreatment, interim, and post-therapy (18)F-FDG PET\/CT in extranodal natural killer\/T-cell lymphoma, nasal type. Ann Nucl Med 29(5):442\u2013451. https:\/\/doi.org\/10.1007\/s12149-015-0964-8","journal-title":"Ann Nucl Med"},{"key":"4466_CR26","doi-asserted-by":"publisher","first-page":"41057","DOI":"10.1038\/srep41057","volume":"7","author":"Y Chang","year":"2017","unstructured":"Chang Y, Fu X, Sun Z, Xie X, Wang R, Li Z, Zhang X, Sheng G, Zhang M (2017) Utility of baseline, interim and end-of-treatment (18)F-FDG PET\/CT in extranodal natural killer\/T-cell lymphoma patients treated with L-asparaginase\/pegaspargase. Sci Rep 7:41057. https:\/\/doi.org\/10.1038\/srep41057","journal-title":"Sci Rep"},{"issue":"13","key":"4466_CR27","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1182\/blood-2017-07-795476","volume":"131","author":"AS Cottereau","year":"2018","unstructured":"Cottereau AS, Versari A, Loft A, Casasnovas O, Bellei M, Ricci R, Bardet S, Castagnoli A, Brice P, Raemaekers J, Deau B, Fortpied C, Raveloarivahy T, Van Zele E, Chartier L, Vander Borght T, Federico M, Hutchings M, Ricardi U, Andre M, Meignan M (2018) Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial. Blood 131(13):1456\u20131463. https:\/\/doi.org\/10.1182\/blood-2017-07-795476","journal-title":"Blood"},{"key":"4466_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2020.1783446","volume":"61","author":"R Guo","year":"2020","unstructured":"Guo R, Xu P, Xu H, Miao Y, Li B (2020) The predictive value of pre-treatment (18)F-FDG PET\/CT on treatment outcome in early-stage extranodal natural killer\/T-cell lymphoma. Leukemia Lymphoma 61:1\u20136. https:\/\/doi.org\/10.1080\/10428194.2020.1783446","journal-title":"Leukemia Lymphoma"},{"issue":"12","key":"4466_CR29","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/RLU.0000000000001375","volume":"41","author":"KY Ko","year":"2016","unstructured":"Ko KY, Liu CJ, Ko CL, Yen RF (2016) Intratumoral heterogeneity of pretreatment 18F-FDG PET images predict disease progression in patients with nasal type extranodal natural killer\/T-cell lymphoma. Clin Nucl Med 41(12):922\u2013926. https:\/\/doi.org\/10.1097\/RLU.0000000000001375","journal-title":"Clin Nucl Med"},{"issue":"5","key":"4466_CR30","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2967\/jnumed.112.110890","volume":"54","author":"A Biggi","year":"2013","unstructured":"Biggi A, Gallamini A, Chauvie S, Hutchings M, Kostakoglu L, Gregianin M, Meignan M, Malkowski B, Hofman MS, Barrington SF (2013) International validation study for interim PET in ABVD-treated, advanced-stage Hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. J Nuclr Med 54(5):683\u2013690. https:\/\/doi.org\/10.2967\/jnumed.112.110890","journal-title":"J Nuclr Med"},{"issue":"1","key":"4466_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1182\/blood-2005-06-2252","volume":"107","author":"M Hutchings","year":"2006","unstructured":"Hutchings M, Loft A, Hansen M, Pedersen LM, Buhl T, Jurlander J, Buus S, Keiding S, D'Amore F, Boesen AM, Berthelsen AK, Specht L (2006) FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 107(1):52\u201359. https:\/\/doi.org\/10.1182\/blood-2005-06-2252","journal-title":"Blood"},{"issue":"10","key":"4466_CR32","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.2967\/jnumed.107.042093","volume":"48","author":"C Lin","year":"2007","unstructured":"Lin C, Itti E, Haioun C, Petegnief Y, Luciani A, Dupuis J, Paone G, Talbot JN, Rahmouni A, Meignan M (2007) Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis. J Nucl Med 48(10):1626\u20131632. https:\/\/doi.org\/10.2967\/jnumed.107.042093","journal-title":"J Nucl Med"},{"issue":"2","key":"4466_CR33","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1016\/S2352-3026(15)00002-2","volume":"2","author":"SJ Kim","year":"2015","unstructured":"Kim SJ, Choi JY, Hyun SH, Ki CS, Oh D, Ahn YC, Ko YH, Choi S, Jung SH, Khong PL, Tang T, Yan X, Lim ST, Kwong YL, Kim WS, Asia Lymphoma Study G (2015) Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer\/T-cell lymphoma, nasal type: a multicentre, retrospective analysis. Lancet Haematol 2(2):e66\u2013e74. https:\/\/doi.org\/10.1016\/S2352-3026(15)00002-2","journal-title":"Lancet Haematol"},{"issue":"4","key":"4466_CR34","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1046\/j.1365-2141.2001.03147.x","volume":"115","author":"R Naumann","year":"2001","unstructured":"Naumann R, Vaic A, Beuthien-Baumann B, Bredow J, Kropp J, Kittner T, Franke WG, Ehninger G (2001) Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma. Br J Haematol 115(4):793\u2013800. https:\/\/doi.org\/10.1046\/j.1365-2141.2001.03147.x","journal-title":"Br J Haematol"},{"issue":"1","key":"4466_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13045-017-0452-9","volume":"10","author":"E Tse","year":"2017","unstructured":"Tse E, Kwong YL (2017) The diagnosis and management of NK\/T-cell lymphomas. J Hematol Oncol 10(1):85. https:\/\/doi.org\/10.1186\/s13045-017-0452-9","journal-title":"J Hematol Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04466-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-021-04466-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04466-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T05:49:55Z","timestamp":1615787395000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-021-04466-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,26]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["4466"],"URL":"https:\/\/doi.org\/10.1007\/s00277-021-04466-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,26]]},"assertion":[{"value":"6 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the ethics committees of all participating centers. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}